🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 10 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/10/2000 | 24,32 | 25,50 | 24,25 | 24,97 | +1,78% | 5,14% | 727.200 |
| 27/10/2000 | 25,34 | 25,56 | 21,25 | 24,53 | -5,31% | 17,02% | 450.000 |
| 26/10/2000 | 25,25 | 26,00 | 25,00 | 25,91 | +3,75% | 3,96% | 634.000 |
| 25/10/2000 | 25,28 | 26,00 | 24,19 | 24,97 | -5,67% | 7,17% | 936.800 |
| 24/10/2000 | 29,56 | 29,56 | 26,03 | 26,47 | -7,03% | 11,94% | 640.600 |
| 23/10/2000 | 29,81 | 29,94 | 28,38 | 28,47 | -4,71% | 5,24% | 916.600 |
| 20/10/2000 | 30,44 | 31,50 | 29,88 | 29,88 | -0,83% | 5,34% | 1.277.000 |
| 19/10/2000 | 30,00 | 31,31 | 29,50 | 30,13 | +1,69% | 6,04% | 485.800 |
| 18/10/2000 | 31,44 | 31,50 | 29,19 | 29,63 | -7,06% | 7,36% | 1.388.200 |
| 17/10/2000 | 36,13 | 36,50 | 31,88 | 31,88 | -11,61% | 12,80% | 882.000 |
| 16/10/2000 | 34,50 | 36,50 | 33,25 | 36,06 | +12,70% | 9,42% | 796.400 |
| 13/10/2000 | 30,00 | 32,31 | 29,50 | 32,00 | +6,22% | 9,38% | 639.600 |
| 12/10/2000 | 30,63 | 31,00 | 29,50 | 30,13 | -1,43% | 4,90% | 1.068.200 |
| 11/10/2000 | 31,13 | 31,13 | 27,50 | 30,56 | -0,61% | 11,65% | 1.388.200 |
| 10/10/2000 | 33,37 | 34,56 | 30,50 | 30,75 | -6,64% | 12,18% | 348.400 |
| 09/10/2000 | 32,53 | 33,44 | 30,56 | 32,94 | -1,68% | 8,84% | 554.600 |
| 06/10/2000 | 36,25 | 36,50 | 32,38 | 33,50 | -10,67% | 11,38% | 1.813.400 |
| 05/10/2000 | 38,56 | 39,19 | 37,50 | 37,50 | -2,76% | 4,38% | 728.200 |
| 04/10/2000 | 39,53 | 39,66 | 36,81 | 38,56 | -2,99% | 7,19% | 881.800 |
| 03/10/2000 | 40,94 | 41,56 | 39,75 | 39,75 | -3,05% | 4,43% | 540.000 |
| 02/10/2000 | 44,31 | 44,31 | 38,38 | 41,00 | -6,15% | 13,40% | 1.239.200 |
| 29/09/2000 | 42,50 | 44,25 | 41,50 | 43,69 | +2,57% | 6,47% | 447.800 |
| 28/09/2000 | 39,66 | 43,19 | 39,50 | 42,59 | +7,07% | 9,30% | 1.280.400 |
| 27/09/2000 | 38,22 | 39,88 | 37,75 | 39,78 | +4,00% | 5,56% | 616.000 |
| 26/09/2000 | 38,44 | 39,06 | 37,63 | 38,25 | -1,77% | 3,74% | 442.400 |
| 25/09/2000 | 37,72 | 39,88 | 37,44 | 38,94 | +4,01% | 6,46% | 800.000 |
| 22/09/2000 | 36,34 | 37,75 | 36,34 | 37,44 | +2,48% | 3,87% | 1.020.600 |
| 21/09/2000 | 37,73 | 38,00 | 36,53 | 36,53 | -3,15% | 3,89% | 146.600 |
| 20/09/2000 | 38,31 | 38,91 | 37,28 | 37,72 | -4,13% | 4,24% | 335.000 |
| 19/09/2000 | 38,22 | 39,97 | 38,03 | 39,34 | +2,19% | 5,07% | 277.200 |